Company Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.
It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters.
In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands.
It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online.
Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
| Country | United States |
| Founded | 1943 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 15,500 |
| CEO | Stuart Randle |
Contact Details
Address: 550 East Swedesford Road, Suite 400 Wayne, Pennsylvania 19087-1603 United States | |
| Phone | 610-225-6800 |
| Website | teleflex.com |
Stock Details
| Ticker Symbol | TFX |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000096943 |
| CUSIP Number | 879369106 |
| ISIN Number | US8793691069 |
| Employer ID | 23-1147939 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Stuart A. Randle | Chief Executive Officer, Interim President and Director |
| Daniel V. Logue J.D. | Corporate Vice President, General Counsel and Secretary |
| John R. Deren | Executive Vice President and Chief Financial Officer |
| Timothy F. Duffy | Vice President and Chief Information Officer |
| Lawrence Soren Keusch | Vice President of Investor Relations and Strategy Development |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer |
| Cameron P. Hicks | Corporate Vice President of Human Resources and Communications |
| James Ferguson | President and GM of Surgical |
| Michelle Fox | Corporate Vice President and Chief Medical Officer |
| Matthew James | President, EMEA and Global Urology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 17, 2026 | 8-K | Current Report |
| Feb 27, 2026 | 10-K | Annual Report |
| Feb 26, 2026 | 8-K | Current Report |
| Feb 12, 2026 | SCHEDULE 13G/A | Filing |
| Feb 11, 2026 | SCHEDULE 13G/A | Filing |
| Jan 23, 2026 | 8-K | Current Report |
| Jan 8, 2026 | 8-K | Current Report |
| Dec 9, 2025 | 8-K | Current Report |
| Nov 14, 2025 | SCHEDULE 13G/A | Filing |
| Nov 14, 2025 | SCHEDULE 13G | Filing |